Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomic and Transcriptomic Biomarkers of Circadian Timing - Validation of Circadian Biomarkers in Patients With Sleep Disorders

NCT04690504 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04690504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04690504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomic and Transcriptomic Biomarkers of Circadian Timing - Validation of Circadian Biomarkers in Patients With Sleep Disorders
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
November 2, 2021
Completion date
July 1, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced sleep phase syndrome (asps), circadian rhythm disorders, circadian rhythm sleep disorder, delayed sleep phase syndrome, sleep disorder, sleep disorders, circadian rhythm, sleep wake disorders